-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vjm3StPDJBLVjDDRJeXecRBabdAytQWKIA+ZPRlyW2xZ6qGEB4Ps595Dp900ERdE e2Z5wvzrIpDznzRgkFg6Tw== 9999999997-10-013573.txt : 20100623 9999999997-10-013573.hdr.sgml : 20100623 20100623154036 ACCESSION NUMBER: 9999999997-10-013573 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100623 DATE AS OF CHANGE: 20100623 20100623 20100623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE GENETICS INC CENTRAL INDEX KEY: 0001124608 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-33509 FILM NUMBER: 10912625 BUSINESS ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 BUSINESS PHONE: (323) 224-3900 MAIL ADDRESS: STREET 1: 1640 MARENGO ST., STREET 2: 6TH FLOOR CITY: LOS ANGELES, STATE: CA ZIP: 90033 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R`P(#`@-C$R M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT M)R-6=MNVT80?3?@?QB@+R1@,^3N M\E8$`1Q9=A34=BO+0(&X*"B)L@C(I"I23=RO[\Q2BD210V\"Q!)]=G9N>^9P M`Q]^AX\?/]P-1M?@?OH$GZ\'\'ER?O;AQ@-/P&1Q?N:!BW\]D&[@N`)"-W(B M!9/7\S,77NB?V_.S;Q;8?\'DZ_G9$!?#\&X`<&39.[*\-R?\R/$4!+'ON+6Y M;];3O:VLT61X#8_VI;0F5_AU8E\*:_AX9/[8BO2E$P5-*[VNB`Y7O#"@D(+( M<\3>R./0EM;@:3R:C,@5=$!:<'5_#<,_!U^NR,_;H7VI+!@\W-V-'A]'#P2[ M9]Q4TG>$:.[0ZZ;LRECH.1[&&H2.VAOYNLU3$/("A.NY7(Z4J\,[7M>[N>K8 M/'8AP%P'1@;\KB0'GN.C%S)V(K$S\C"^'F(FQW!+J1Q3N>\GH_M;3.K]S>AZ MB%_HV6]`/3`9#Z\FMF_=#76F)URJ?=?Q17.?7F>#+F>Q.6-,M=`M?]2$`'SZ-[4L?^W94=PEV"`&P2VZ'<#68T+.'&_!B23#%^BVIA1M; M]OH=,E7R!+6:@8&HJ\>4[P0!^''DJ+V1<5JNB[Q,X3:E.N1IE5%\L_("1OG, MX;HN"!RIFI9ZW8D[W-EQCA\I)S`RXKE=04E)K>>'[J$E;K)52E'`?>$`$X)` M7O"#YCJ/PT:BA;UDL6@W:F(EAXT%M7,3Z[LQEW4O:,&Y\*07M["VT#6Y^8=DI:GDA?+:IW#:XIP%/L0&'#=M9#EELV^'^GNPET2SPND8961`Q=51_*WDU&S:P M1W2$5$1G.'N'BH3R'&6VH5!*L]8QMMQ.7^W0RO1>E>;`.20Y).OUJMX^(484 M5H'3*8=M/D\W])4]'RA6PI,]QMQ4<*43GB1@N\*)@E-?35FU$3LR:"[B#K:B M0D9-K("-CO*?+0:4EG6.\Q+^HR+D#1Z?M&,F>3-=O`N^2-Q8K M74U`QW!NCGHR:&$YR>0IT<+V*F$O;"_@2,,+_1:VG^@8V:PB_:)C8J%+-Y.% M4'63;0=5-K"?DS*=`QXBS4;%? M]<\V6>DEBRPM:S[WK:0$HC?\A`RGU7`MAA/,+1(=JN+B]9584V=\I@FI-D.K MBPTLLCRITT3,F-D_6<^^##2C'?RD04*?-Z"SO$SA9D/,G\X+"@@T=2[ZPE'! M@2=&F#+-AH<-KF;5!?CPY#PZ`P?U@7BVIL_VLT6[J6<;][KXR:_7V;]9F=43 MKEC`0$>S+C2M'RS>Z(`Q0DS'+*5\+#%C=1A5NJ'XLOQ=JE)2',Y<7E1U_`6L MM]-5-L.=5V\PUVDO9[C%JBAK*4]5J1S`N&;%9EZ[\J+A%Z`WQ1E"/[9SJM`< M?=2-=)(5/5W\YG31)5JMV%+[)RND.+QHGRGU0\4><#VI M&PNQ5AP87_:;V))E7*&)HV'7[J?G!IBG_;B%_9Y1/;1L`JKL-"6M@6Z$B-W)>X(NE::"[ M^Q$S;*V6&MAJJ0].L7U9]HWBTSBUUI.6Q]YE80,B5376:&'6_Q+2P',7(DJU M;?=W:-<]%W5H&'8K[K:%KJLILD#JZ+W;D'V/<]CV#777%1;MAH<;.6QW?55L M:K)$53!`.:`T$V9E6?,@*^^1K!IV+DC\G)H:RSC^)"F5=B$]J>^ MZZ:&?!2"WKM,+'3]_P)9<",G-+/`W)>(6#FQF07F141$WJ'P[[2K&;:F9#-L M3I_`E>4O9*8\O+F'/'NT*,"]R(@B[.[&K M`D;8706,L+L*F&#W%3#"[BI@@MU7X!C[>8-4LH3!,DL7;`%<&I_L%NT",+I& M^-+T(#.Z1J"HY0_R_\("#W`-"F5N9'-T7!E+T9O;G0O4W5B='EP92]47!E+T9O;G1$97-C7!E+T]B:E-T;2].(#,R M+T9I^XP!G#G#F`&<.<.8`9_Z;#`.MU6J2W/IJW!R(1=V\7EVO*V273R%/84]A3U%/$4\13Q%/$4\13Q% M/$4\13Q%/$4]13U%UY1[G+=W^_4V3\?E]/&XW)[F^?#ZNDS[A]/\LI;CV!M[ M7_\;G_?K[2'+/*=G"2+*UGU?;#>2%_N\'3"P\E:>#OYRREN3ME)B3U$M7"$`_QV M)[NL+O\I0`(#&,((QI#"!#+(H8`2*IA"A!H:F,$<%K"$%:QA`UO8P=XRQ+.' MKJ_2!X"6"X@-"F5N9'-TF4@-#8O4F]O="`Q(#`@ M4B]);F9O(#D@,"!2+TE$6SPX0C,U1$0R-3@R1D0S1C1"0C$Q,$4Y.3!%1$$V M-4,V,3X\.$(S-41$,C4X,D9$,T8T0D(Q,3!%.3DP141!-C5#-C$^72`^/@T* M')E9@T*,"`P#0IT -----END PRIVACY-ENHANCED MESSAGE-----